Publications by authors named "Mark Bach"

Claim this Profile
A
Average IGF-1 Prediction for Once-Weekly Lonapegsomatropin in Children With Growth Hormone Deficiency.
Zhengning Lin, Aimee D Shu, Mark Bach, Bradley S Miller, Alan D Rogol

J Endocr Soc· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Potentially Prolactin-Related Adverse Events and Sexual Maturation in Adolescents with Schizophrenia Treated with Paliperidone Extended-Release (ER) for 2 Years: A Post Hoc Analysis of an Open-Label Multicenter Study.
Srihari Gopal, Rosanne Lane, Isaac Nuamah, Margaret Copenhaver, Jaskaran Singh, Mark Bach

CNS Drugs· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissecting the workforce and workplace for clinical endocrinology, and the work of endocrinologists early in their careers.
Claude Desjardins, Mark A Bach, Anne R Cappola, Ellen W Seely, Ronald G Ehrenberg

J Clin Endocrinol Metab· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.
Ralf Nass, Suzan S Pezzoli, Mary Clancy Oliveri, James T Patrie, Frank E Harrell, Mark A Bach

Ann Intern Med· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Endocrine Society Ethics Advisory Committee: ethical aspects of conflicts of interests, October 2003.
Paul A Komesaroff, Mark A Bach, Ann Danoff, Melvin M Grumbach, Selna Kaplan

Endocrinology· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture.
Mark A Bach, Kenneth Rockwood, Carl Zetterberg, Gorm Thamsborg, Réjean Hébert

J Am Geriatr Soc· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis.
J Curtis Nickel, Michel Pontari, Timothy Moon, Marc Gittelman, Gholam Malek, Mark Bach

J Urol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia.
Hunter Wessells, Johnny Roy, John Bannow, John Grayhack, Alvin M Matsumoto, Stephen Auerbach, Mark A Bach

Urology· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis